Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05585619 · ClinicalTrials.gov registry record

Difficult Encounters in Pain Medicine

A clinical trial of Chronic Pain, sponsored by Johns Hopkins University.

Completed
Registry status
428
Enrollment target
1
Study location

NCT05585619: Completed study of Chronic Pain, sponsored by Johns Hopkins University.

NCT05585619 is a study of Chronic Pain that has completed, run by Johns Hopkins University. The registered enrollment target is 428 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05585619, a study of Chronic Pain, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
428 participants
Enrollment target
1
Study location

Study Summary

The investigators are seeking to determine factors associated with difficult patient encounters in an academic pain clinic. The investigators are examining 36 different variables to determine the association with "difficult" patient encounters as independently rated by a trainee and attending physician.

Primary Outcome

Difficulty of encounter as rated by a 6-point Likert scale (1=very pleasant, 6=extremely difficult)

Conditions Studied

Interventions

  • OTHER Pain treatment

Study Locations (1)

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 428 participants
Start Date 2022-10-10
Est. Completion 2024-03-29
Johns Hopkins University

1,448 total trials

What the finished NCT05585619 record still lists

NCT05585619 is an observational study that tracks outcomes without assigning an intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (44% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Pain treatment is the first listed.

NCT05585619 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05585619 about?

NCT05585619 is a clinical study titled "Difficult Encounters in Pain Medicine". The investigators are seeking to determine factors associated with difficult patient encounters in an academic pain clinic. The investigators are examining 36 different variables to determine the association with "difficult" patient encounters as independently rated by a trainee and attending physic...

What is the current status of trial NCT05585619?

This trial is currently completed. The enrollment target is 428 participants. The study started on 2022-10-10. Estimated completion is 2024-03-29.

What conditions does trial NCT05585619 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT05585619?

The interventions under investigation include: Pain treatment (OTHER).

Who is sponsoring clinical trial NCT05585619?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05585619 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05585619's enrollment target sits among peer trials

428 30th of 301 higher than 272 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05566431 · 428 participants · NA

    Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics

  • NCT05646316 · 428 participants · Phase 3

    Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

  • NCT05797610 · 428 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

  • NCT06073626 · 428 participants · NA

    Addressing Genomic Disparities in Cancer Survivors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05585619, the US trial registry maintained by the National Library of Medicine. NCT05585619 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.